Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force

Mukhtyar, C.; Flossmann, O.; Hellmich, B.; Bacon, P.; Cid, M.; Cohen-Tervaert, J.; Gross, W.; Guillevin, L.; Jayne, D.; Mahr, A.; Merkel, P.; Raspe, H.; Scott, D.; Witter, J.; Yazici, H.; Luqmani, R.

doi:10.1136/ard.2007.071936

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force

Mukhtyar C., Flossmann O., Hellmich B., Bacon P., Cid M., Cohen-Tervaert J. W., ...Daha Fazla

ANNALS OF THE RHEUMATIC DISEASES, cilt.67, sa.7, ss.1004-1010, 2008 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 67 Sayı: 7
Basım Tarihi: 2008
Doi Numarası: 10.1136/ard.2007.071936
Dergi Adı: ANNALS OF THE RHEUMATIC DISEASES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1004-1010
İstanbul Üniversitesi Adresli: Evet

Özet

Objectives: We undertook a systematic literature review as a background to the European League Against Rheumatism (EULAR) recommendations for conducting clinical trials in anti-neutrophil cytoplasm antibody associated vasculitis (AAV), and to assess the quality of evidence for outcome measures in AAV.